Ergoteles’s Global Blood Therapeutics, Inc. GBT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-96,027
| Closed | -$6.54M | – | 2178 |
|
|
2022
Q3 | $6.54M | Buy |
96,027
+87,544
| +1,032% | +$5.96M | 0.23% | 88 |
|
|
2022
Q2 | $271K | Buy |
+8,483
| New | +$271K | 0.01% | 1162 |
|
|
2022
Q1 | – | Sell |
-9,263
| Closed | -$271K | – | 1760 |
|
|
2021
Q4 | $271K | Buy |
+9,263
| New | +$271K | 0.01% | 899 |
|
|
2021
Q2 | – | Sell |
-91,449
| Closed | -$3.73M | – | 1753 |
|
|
2021
Q1 | $3.73M | Buy |
+91,449
| New | +$3.73M | 0.12% | 201 |
|
|
2020
Q4 | – | Sell |
-52,126
| Closed | -$2.87M | – | 980 |
|
|
2020
Q3 | $2.87M | Buy |
+52,126
| New | +$2.87M | 0.38% | 51 |
|